The UK’s biggest investor has cautiously supported Sir Pascal Soriot’s controversial AstraZeneca pay deal, but warned that a successor shouldn’t expect the same treatment. Legal & General voted in favor
Fitnesses and Wellbeing2- Page
17Articles
- 1
- 2
